PredictImmune Investors
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Investor Type:
Healthcare Company
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2017
Industry:
P4 Medicine